5,702 Shares in Enhabit, Inc. (NYSE:EHAB) Purchased by Quantbot Technologies LP

Quantbot Technologies LP purchased a new position in Enhabit, Inc. (NYSE:EHAB) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 5,702 shares of the company’s stock, valued at approximately $45,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of EHAB. Jane Street Group LLC raised its holdings in shares of Enhabit by 514.3% in the 3rd quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock worth $7,119,000 after purchasing an additional 754,395 shares in the last quarter. Paradice Investment Management LLC grew its position in Enhabit by 12.8% in the fourth quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company’s stock worth $13,903,000 after buying an additional 201,997 shares during the last quarter. Systematic Financial Management LP increased its holdings in shares of Enhabit by 12.2% in the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after buying an additional 199,235 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Enhabit by 37.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company’s stock valued at $2,411,000 after acquiring an additional 83,707 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. boosted its stake in shares of Enhabit by 484.4% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 69,409 shares of the company’s stock worth $548,000 after acquiring an additional 57,532 shares in the last quarter.

Enhabit Stock Down 0.8 %

EHAB stock opened at $8.72 on Wednesday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The firm has a market capitalization of $440.34 million, a P/E ratio of -3.76 and a beta of 1.80. Enhabit, Inc. has a 52-week low of $6.85 and a 52-week high of $11.35. The company’s 50 day simple moving average is $8.54 and its 200-day simple moving average is $7.99.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reaffirmed a “buy” rating on shares of Enhabit in a report on Thursday, March 6th.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.